EP
Eversept Partners Portfolio holdings
AUM
$992M
This Quarter Return
+19.09%
1 Year Return
+2.54%
3 Year Return
+103.47%
5 Year Return
+181.01%
10 Year Return
–
AUM
$198M
AUM Growth
+$198M
(+32%)
Cap. Flow
+$36.1M
Cap. Flow
% of AUM
18.21%
Top 10 Holdings %
Top 10 Hldgs %
56.63%
Holding
67
New
20
Increased
11
Reduced
18
Closed
11
Top Buys
| 1 |
QCP
Quality Care Properties, Inc.
QCP
|
$15.2M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
$9.4M |
| 3 |
GSK
GSK
|
$8.95M |
| 4 |
ARNA
Arena Pharmaceuticals Inc
ARNA
|
$8.72M |
| 5 |
AVXS
AveXis, Inc. Common Stock
AVXS
|
$6.28M |
Top Sells
| 1 |
ARRY
Array Biopharma Inc
ARRY
|
$14.4M |
| 2 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$4.01M |
| 3 |
eHealth
EHTH
|
$3.63M |
| 4 |
EVHC
Envision Healthcare Holdings Inc
EVHC
|
$2.69M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
$2.17M |
Sector Composition
| 1 | Healthcare | 68.17% |
| 2 | Real Estate | 10.84% |
| 3 | Industrials | 6.87% |
| 4 | Financials | 0.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
QCP
1
DELISTED
Quality Care Properties, Inc.
QCP
| $20M | 9.3% | 1,030,661 +782,015 | +315% | +$15.2M |
|
|
RCM
2
DELISTED
R1 RCM Inc. Common Stock
RCM
| $13.6M | 6.33% | 1,909,887 +268,009 | +16% | +$1.91M |
|
|
RDUS
3
DELISTED
Radius Health, Inc.
RDUS
| $12M | 5.57% | 333,738 +139,237 | +72% | +$5M |
|
|
AERI
4
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $11.4M | 5.31% | 210,778 -30,702 | -13% | -$1.67M |
|
|
ABLX
5
DELISTED
Ablynx NV American Depositary Shares
ABLX
| $9.92M | 4.61% | 181,891 +81,012 | +80% | +$4.42M |
|
|
AVXS
6
DELISTED
AveXis, Inc. Common Stock
AVXS
| $9.66M | 4.49% | 78,201 +50,831 | +186% | +$6.28M |
|
|
7
Alnylam Pharmaceuticals
ALNY
$58.5B
| $9.4M | 4.36% | +78,893 | New | +$9.4M |
|
|
8
GSK
GSK
$79.9B
| $8.95M | 4.16% | +226,584 | New | +$8.95M |
|
|
ARNA
9
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $8.72M | 4.05% | +220,788 | New | +$8.72M |
|
10
The Ensign Group
ENSG
$9.91B
| $8.59M | 3.99% | 325,897 -5,850 | -2% | -$154K |
|
|
ZGNX
11
DELISTED
Zogenix, Inc.
ZGNX
| $8.19M | 3.8% | 204,546 -13,832 | -6% | -$554K |
|
|
12
Vertex Pharmaceuticals
VRTX
$100B
| $7.31M | 3.39% | 44,822 -13,300 | -23% | -$2.17M |
|
|
ARRY
13
DELISTED
Array Biopharma Inc
ARRY
| $5.84M | 2.71% | 357,727 -880,076 | -71% | -$14.4M |
|
14
Sanofi
SNY
$121B
| $5.53M | 2.57% | 137,972 -50,000 | -27% | -$2M |
|
|
NVRO
15
DELISTED
NEVRO CORP.
NVRO
| $5.27M | 2.45% | 60,850 -4,000 | -6% | -$347K |
|
|
TLGT
16
DELISTED
Teligent, Inc
TLGT
| $5.21M | 2.42% | 1,550,383 -110,502 | -7% | -$371K |
|
|
SAGE
17
DELISTED
Sage Therapeutics
SAGE
| $3.87M | 1.8% | +24,000 | New | +$3.87M |
|
18
BioMarin Pharmaceuticals
BMRN
$11.2B
| $3.73M | 1.73% | 46,000 +300 | +0.7% | +$24.3K |
|
|
TSRO
19
DELISTED
TESARO, Inc.
TSRO
| $2.94M | 1.37% | 51,523 -34,217 | -40% | -$1.96M |
|
20
argenx
ARGX
$43.6B
| $2.88M | 1.34% | 35,784 +8,124 | +29% | +$653K |
|
21
Abbott
ABT
$231B
| $2.87M | 1.33% | +47,900 | New | +$2.87M |
|
22
TG Therapeutics
TGTX
$4.65B
| $2.13M | 0.99% | +150,000 | New | +$2.13M |
|
|
ABMD
23
DELISTED
Abiomed Inc
ABMD
| $2.06M | 0.96% | 7,094 -1,500 | -17% | -$436K |
|
|
MYOK
24
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $2.05M | 0.95% | 42,000 -8,000 | -16% | -$390K |
|
|
IVC
25
DELISTED
Invacare Corporation
IVC
| $1.74M | 0.81% | 99,902 +2,600 | +3% | +$45.2K |
|